Prescription Drugs (legal action)
Prescription drugs have become central to medical care in the past twenty years, and the cost of them consequently has become a major factor in the larger health care cost equation. Too much of the increased cost of drugs is caused by drug companies’ use of illegal tactics and practices to either keep the price of drugs artificially high or increase the sales of their products.
Community Catalyst works with a coalition of over 130 consumer advocacy organizations, labor unions, and nonprofit health plans to ensure that the millions of consumers and health plans who have been overcharged get reimbursed, and that the companies who engage in these tactics face real consequences. Through comprehensive litigation to challenge manipulative pricing and deceptive advertising, we expose illegal practices and work to change the culture of acceptable and responsible corporate behavior.
- March 01, 2011 Data mining amicus brief filed with the Supreme Court Amicus brief filed with the Supreme Court regarding the role of data mining in driving illegal promotions of off-label drugs by Community Catalyst, Prescription Access Litigation, Health Care for All MA and AFSCME D.C.
- June 25, 2010 Prescription Access Litigation Comments on FDA's notice on Direct-to-Consumer Advertisements Community Catalyst's PAL coalition and 22 other groups weigh in on FDA's notice on making risks clear, conspicuous and neutral in broadcast drug ads
- August 31, 2007 Legal Analysis: The Constitutional Battle Over State Regulation of Data Mining This article provides a brief explanation of the legal and policy background for state regulation of data mining and “detailing” in the pharmaceutical industry and explains some recent state responses to the New Hampshire decision.
- August 30, 2007 | from The Prescription Project A Fact Sheet on Data Mining A fact sheet on data mining
- August 30, 2007 | from The Prescription Project Data Mining: Myths and Rebuttals Frequently asked questions about data mining
- November 01, 2003 Poison Pills in the Medicare Prescription Drug Deal A brief on the new Medicare prescription drug deal